Early clinical results of proton spatially fractionated GRID radiation therapy (SFGRT)

Author:

Mohiuddin Majid12ORCID,Lynch Connor1,Gao Mingcheng1,Hartsell William12

Affiliation:

1. Northwestern Medicine Chicago Proton Center 4455 Weaver Pkwy, Warrenville, IL 60555

2. Radiation Oncology Consultants, Ltd. 700 Commerce Drive, Suite 500, Oak Brook, IL 60523

Abstract

Objective: Approximately 70 patients with large and bulky tumors refractory to prior treatments were treated with photon spatially fractionated GRID radiation (SFGRT). We identified 10 additional patients who clinically needed GRID but could not be treated with photons due to adjacent critical organs. We developed a proton SFGRT technique, and we report treatment of these 10 patients. Methods: Subject data were reviewed for clinical results and dosimetric data. 50% of the patients were metastatic at the time of treatment and five had previous photon radiation to the local site but not via GRID. They were treated with 15–20 cobalt Gray equivalent using a single proton GRID field with an average beamlet count of 22.6 (range 7–51). 80% received an average adjuvant radiation dose to the GRID region of 40.8Gy (range 13.7–63.8Gy). Four received subsequent systemic therapy. Results: The median follow-up time was 5.9 months (1.1–18.9). At last follow-up, seven patients were alive and three had died. Two patients who had died from metastatic disease had local shrinkage of tumor. Of those alive, four had complete or partial response, two had partial response but later progressed, and one had no response. For all patients, the tumor regression/local symptom improvement rate was 80%. 50% had acute side-effects of grade1/2 only and all were well-tolerated. Conclusion: In circumstances where patients cannot receive photon GRID, proton SFGRT is clinically feasible and effective, with a similar side-effect profile. Advances in knowledge: Proton GRID should be considered as a treatment option earlier in the disease course for patients who cannot be treated by photon GRID.

Publisher

British Institute of Radiology

Subject

Radiology Nuclear Medicine and imaging,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3